Healthcare spending in the United States is growing faster than the economy itself, and the gap is widening. National health expenditure is projected to grow at 5.8 percent annually through 2033, outpacing GDP growth of 4.3 percent. By 2033, healthcare will consume 20.3 percent of GDP, up from 17.6 percent in 2023. No single villain explains this trend. Rising costs are the product of several forces pushing prices up simultaneously.
Administrative Complexity Is the Biggest Excess Cost
The single largest reason the U.S. spends more than comparable countries isn’t fancier hospitals or more doctor visits. It’s paperwork. Administrative costs, split between insurers and healthcare providers, account for roughly 30 percent of excess U.S. spending compared to peer nations. On the insurance side, the costs of verifying eligibility, coding claims, submitting paperwork, and reworking rejected claims represent about 15 percent of that excess. Providers shoulder another 15 percent through general administration, human resources departments, and quality reporting requirements.
In raw numbers, the U.S. spent $1,055 per person on healthcare administration in 2020. The average across a dozen comparable wealthy nations was $193 per person, roughly five times less. That gap exists largely because the U.S. system requires providers to navigate hundreds of different insurance plans, each with its own rules for coverage, prior authorization, and billing. Every layer of complexity adds staff, software, and time that other countries’ simpler systems don’t require.
Hospital Consolidation Drives Prices Up
When hospitals merge or join large health systems, prices tend to rise rather than fall. Research from Harvard Business School found that hospitals gaining a new system member within the same state saw commercial insurance prices increase by 7 to 10 percent. The effect was strongest when the merging hospitals were geographically close to each other, roughly 30 to 90 minutes apart by car. Four years after gaining a nearby system member, prices at those hospitals were 19 percent higher than at comparable hospitals that hadn’t merged.
These price increases aren’t explained by improvements in care quality. The data shows that acquiring hospitals are raising their own prices after a deal closes, not investing in better outcomes. Consolidation gives health systems more leverage when negotiating with insurers, and that leverage translates directly into higher prices for patients and employers. This pattern has accelerated over the past two decades as independent hospitals have increasingly been absorbed into regional and national chains.
An Aging Population With More Chronic Disease
The baby boomer generation is reshaping the cost landscape as it ages into Medicare. By 2030, Medicare spending in constant dollars is expected to more than double, from $510 billion to $1.2 trillion. The sheer number of people turning 65 is the biggest driver, but it’s not just volume. Today’s older adults are living longer, which is good news, but they’re also more likely to be obese, disabled, and managing multiple chronic conditions than previous generations were at the same age. A typical 65-year-old in 2010 was estimated to generate $131,000 in lifetime Medicare spending. By 2030, that figure is projected to reach $223,000, a 72 percent increase driven by longer life expectancy, more chronic illness, and rising medical prices.
Chronic conditions are where the real money goes across all age groups, not just seniors. Ninety percent of the nation’s $4.9 trillion in annual healthcare spending goes toward people with chronic and mental health conditions. Diabetes, heart disease, cancer, and similar long-term illnesses require ongoing medications, regular monitoring, and periodic hospitalizations that accumulate enormous costs year after year. As rates of obesity and related conditions continue to climb, this spending category keeps expanding.
New Technology Adds Cost and Value
Medical innovation is one of the most paradoxical cost drivers. New treatments, devices, imaging tools, and surgical techniques often deliver genuinely better outcomes. Cancer survival rates have improved. Minimally invasive procedures mean shorter hospital stays. Gene therapies can now treat previously untreatable conditions. But each of these advances comes with a price tag, and the overall effect is to push per-patient spending higher.
Unlike in most industries, where new technology eventually lowers prices (think flat-screen TVs or smartphones), medical technology tends to expand the range of treatable conditions and increase the intensity of care without replacing older, cheaper options. A new cardiac imaging device doesn’t eliminate the need for basic blood work. It gets added on top. This layering effect means that as medicine gets better at diagnosing and treating disease, the total cost of care per person trends upward. Research from the Bureau of Economic Analysis identifies medical innovation as a key driver of both improved life expectancy and cost growth, reflecting this fundamental tension.
Higher Prices for the Same Services
A significant share of excess U.S. spending comes not from Americans using more healthcare, but from paying more for the same services. Physician wages account for about 10 percent of excess spending compared to peer countries. Nursing wages add another 5 percent. Prescription drugs contribute roughly 10 percent. Medical machinery and equipment account for a smaller but still meaningful share. These aren’t categories where Americans are getting more care. They’re categories where the unit price is simply higher.
Prescription drugs illustrate this clearly. Brand-name drug manufacturers routinely raise list prices year over year, often well above the rate of inflation. While rebates and discounts reduce what insurers actually pay, the list price increases cascade through the system, affecting copays, deductibles, and premiums. New specialty medications for conditions like cancer, autoimmune diseases, and rare genetic disorders can cost tens or hundreds of thousands of dollars per year per patient, and these drugs represent a growing share of total pharmaceutical spending.
Defensive Medicine and Systemic Waste
Doctors in the U.S. practice in a legal environment that encourages ordering extra tests and procedures to protect against malpractice lawsuits, a pattern known as defensive medicine. This adds an estimated $50 billion annually to the national healthcare bill. That figure includes unnecessary imaging scans, redundant lab work, specialist referrals made out of caution rather than clinical need, and hospital admissions that could safely be avoided.
Defensive medicine is just one form of waste in a system with many. Unnecessary services, inefficiently delivered care, fraud, and failures of care coordination all contribute. When a patient sees multiple specialists who don’t communicate with each other, tests get repeated, medications conflict, and problems that could have been caught early become expensive emergencies. These inefficiencies don’t show up as a single line item in any budget, but collectively they represent hundreds of billions of dollars in spending that doesn’t improve anyone’s health.
Why These Forces Are Hard to Reverse
Each of these cost drivers reinforces the others. Administrative complexity makes it harder for small, independent practices to survive, which accelerates consolidation, which raises prices. An aging population with more chronic disease increases demand for new treatments and technologies, which adds cost. Higher prices across the board make insurance more expensive, which makes the administrative burden of managing coverage heavier.
The U.S. is projected to cross the threshold of spending one-fifth of its entire economy on healthcare within the next decade. That trajectory reflects not a single policy failure but a system where every major player, from hospitals to insurers to drug companies to patients, faces incentives that push spending upward. Bending that curve requires changing multiple incentives at once, which is why healthcare costs have risen steadily under every presidential administration for decades regardless of which party held power.